|
|
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
|
|
|
TOPIC: Alfia Weight Loss Capsules by iSlim: Public Notification - Due to Hidden Drug Ingredient
AUDIENCE: Consumer, Health Professional, Pharmacy
ISSUE: The FDA is advising consumers not to purchase or use Alfia Weight Loss Capsules because FDA laboratory analysis confirmed that Alfia Weight Loss Capsules contain sibutramine.
Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or heart rate in some people and may present a significant risk for people with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking.
For more information about this alert, click on the red button "Read Alert" below.
BACKGROUND: Alfa Weight Loss Capsules is a product promoted and sold for weight loss on various websites including, https://alfia.com, and possibly in some retail stores.
RECOMMENDATIONS:
-
Health care professionals and consumers should report adverse events or side effects related to the use of this product.
-
Consumers should exercise caution before purchasing any weight loss product.
-
Please refer to the links below for more information:
Tainted Weight Loss Products
Dietary Supplements
|
|
|
Health professionals and consumers are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report online.
-
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.
|
|
|
|
